HGH (Human Growth Hormone)
42iu / 10iu
Select Strength
Riptide Health provides comprehensive educational resources on research peptides. Product availability and research applications are discussed directly with our team.
Availability: In Stock
For research purposes only
What Is HGH?
Human Growth Hormone (HGH), also known as somatropin, is a naturally occurring protein hormone produced by the anterior pituitary gland. It is a complete 191-amino acid polypeptide — the full-length growth hormone molecule — and serves as the body's master regulator of growth, metabolism, body composition, and cellular repair.
HGH is produced throughout life, peaking during adolescence. Levels decline progressively with age in a process known as the somatopause, contributing to increased visceral fat, reduced lean muscle, decreased bone density, reduced energy, and impaired recovery.
⚠️ Regulatory Note: Somatropin is a Schedule 4 (prescription only) medicine in Australia under the TGA. This product is supplied strictly for research purposes only and is not intended for human therapeutic use. Riptide Health does not promote, supply, or endorse the use of somatropin outside of lawful research contexts. Consult a qualified medical professional before considering any peptide protocol.
How It Works
HGH operates via two primary pathways:
- Direct GH Receptor Binding — binds growth hormone receptors on liver, muscle, bone, and adipose tissue, directly stimulating lipolysis, protein synthesis, and bone mineralisation.
- IGF-1 Mediation — triggers hepatic production of Insulin-like Growth Factor-1 (IGF-1), which drives the majority of HGH's anabolic effects: skeletal muscle hypertrophy, bone and cartilage growth, organ maintenance, and cellular repair.
Research-Backed Benefits
- Significant reductions in visceral and total body fat
- Increases in lean muscle mass and strength
- Improvements in bone mineral density
- Enhanced wound healing and post-surgical recovery
- Improved skin thickness and collagen content
- Quality of life improvements in growth hormone deficiency — supported by decades of clinical trial data
Dosing & Administration
Route: Subcutaneous injection following reconstitution with bacteriostatic water. Avoid injecting around carbohydrate-heavy meals — elevated insulin blunts GH activity.
Protocol 1 — Anti-Ageing / General Wellness
| Dose | Frequency | Duration |
|---|---|---|
| 1–2 IU | Once daily SubQ, before bed or morning fasted | 6 months on, 1–3 months off |
Low-dose approach minimises side effects. Before-bed dosing mimics the natural GH pulse. Monitor IGF-1 every 3 months; target 200–300 ng/mL.
Protocol 2 — Body Composition / Performance
| Dose | Frequency | Duration |
|---|---|---|
| 2–4 IU | Once or twice daily SubQ | 6–12 months cycling |
Split dosing: morning fasted + post-workout. Higher doses increase fat loss and muscle gain but raise side effect risk. Monitor fasting glucose and HbA1c.
Protocol 3 — Advanced Bodybuilding
| Dose | Frequency | Duration |
|---|---|---|
| 4–8 IU | Daily SubQ split across 2 doses | 12–24 weeks on, 8–12 weeks off |
High-dose protocols warrant close physician supervision. Insulin co-administration is sometimes used (extreme risk — do not undertake without expert guidance). Monitor IGF-1, glucose, and HbA1c regularly.
Reconstitution:
- Add bacteriostatic water gently to lyophilised powder — swirl, do not shake
- Refrigerate at 2–8°C and use within 28 days
- Discard if cloudy or particulate matter is visible
⚠️ Dosing should always be determined in consultation with a qualified healthcare professional. For research purposes only.
Enter your dose and BAC water volume to calculate your exact draw amount.
Enter all values above to see your draw volume.
For research reference only. Always verify volumes independently.
Third-Party Lab Results
The following certificates present full, unmodified analytical data for each product batch, including purity percentage and HPLC chromatogram. Supplier and laboratory identification details have been redacted — see our disclaimer for details.
Side Effects & Safety
- Water retention (oedema), particularly at higher doses
- Carpal tunnel syndrome — dose-dependent, typically resolves on dose reduction
- Joint and muscle discomfort
- Potential for elevated blood glucose and insulin resistance at higher doses
- Risk of promoting growth in undiagnosed hormone-sensitive malignancies — screening advised prior to use
Full HGH significantly elevates IGF-1 and has a broader systemic effect than isolated peptide fragments. Risk profile is substantially higher than research peptides such as HGH Fragment 176-191 or GH secretagogues (CJC-1295, Ipamorelin, Sermorelin).
Synergy Stacks
- HGH + CJC-1295 + Ipamorelin — amplified GH axis stimulation for body recomposition
- HGH + Tesamorelin — targeted visceral fat reduction with complementary GHRH activity
- HGH + BPC-157 + TB-500 — accelerated tissue repair and recovery
- HGH + NAD+ — cellular energy and longevity support alongside GH-driven repair
TGA Disclaimer
This product is supplied strictly for research and laboratory purposes only. It is not approved by the Therapeutic Goods Administration (TGA) for human therapeutic use and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Somatropin is a Schedule 4 prescription-only medicine in Australia — Riptide Health does not promote or endorse its use outside lawful research contexts. This product should not be administered to humans or animals without appropriate medical supervision. Consult a qualified medical professional before considering any peptide protocol. Riptide Health complies fully with all applicable Australian regulations.
Preparing this vial? Lyophilised peptides are reconstituted with bacteriostatic water, available in the shop.
All products are sold strictly for research purposes only. By purchasing, you confirm that you understand and comply with all applicable laws and regulations in your jurisdiction regarding the acquisition and use of research compounds. These products are not intended for human consumption, therapeutic use, or veterinary use. They have not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory authority. Riptide Health accepts no liability for misuse of any product.